Monitoring anti-Rituximab antibodies in myasthenia gravis affects the time to event during Rituximab treatment
{{output}}
Introduction: Rituximab (RTX) effectively manages myasthenia gravis (MG) by reducing relapse rates. Anti-Rituximab antibodies can develop in autoimmune diseases and may lead to RTX resistance. Although RTX infusions are increased... ...
